It was also found that AQP2 protein expression is reduced in kidney cancer tissue, however, the number of clinical samples have to be expanded, with combination of liquid biopsy (blood, urine) analysis to explore the application potential of MIAC and AQP2 as biomarkers for kidney cancer diagnosis and prognosis. Here, AQP2 is linked to kidney cancer.